The journey to space starts with the engines.
Ursa Major was founded to bring a new model to space access: one in which every link in an enormous value chain isn’t limited by those around it. We design rocket engines and propulsion solutions.
Our products and technologies require an extraordinary team. A team who will mold tomorrow’s technologies while deploying today’s best. We are comprised of intrinsically motivated individuals who have a passion for solving problems and empower each other every day to develop our skills, knowing that there is always room for growth.
Ursa Major’s team moves fast and does a lot with little. The Director of Government Business Development will be responsible for Ursa Major’s strategic business development efforts within the DoD and Federal Agencies. We are looking for an innovative problem solver and team player who has robust connections within relevant government organizations and thorough knowledge of the current federal trends surrounding liquid rocket engines. This person will also have a deep understanding of the government acquisition process.
Whilst our preference is to have this position based out of Washington D.C., we would also consider Colorado as an alternative location.
US CITIZENSHIP OR PERMANENT RESIDENCY IS REQUIRED.
We’re an equal opportunity employer. You will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
No outside recruiters please.
URSA'S COVID POLICY:
As a U.S. government contractor, Ursa Major is subject to President Biden’s September 9, 2021 Executive Order on Ensuring Adequate COVID Safety Protocols for Federal Contractors requiring federal contractors to be fully vaccinated from COVID-19. As such, Ursa Major requires employees to either show proof of vaccination or demonstrate an exemption for medical or religious reasons by December 8, 2021. Per the executive order, “fully vaccinated” means two weeks after a final dose of a one- or two-dose COVID-19 vaccine approved for regular or emergency use by the U.S. Food and Drug Administration or World Health Organization.